Company Filing History:
Years Active: 1997
Title: Reimar C Bruening: Innovator in Antifungal and Hypoglycemic Agents
Introduction
Reimar C Bruening is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antifungal and hypoglycemic properties. With a total of three patents to his name, Bruening's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Among his latest patents, Bruening has developed a class of phosphocholine derivatives that exhibit antifungal activity. Additionally, he has worked on hypoglycemic agents derived from Cryptolepis, specifically focusing on the use of extracts from Cryptolepis sanguinolenta. These extracts and quindoline alkaloids, such as quindoline and cryptolepine, are designed to treat both insulin-dependent (type I) and non-insulin-dependent (type II) diabetes.
Career Highlights
Reimar C Bruening is associated with Shaman Pharmaceuticals, Inc., where he has been instrumental in advancing research and development in the pharmaceutical sector. His innovative approaches have led to the creation of valuable therapeutic agents that address critical health issues.
Collaborations
Throughout his career, Bruening has collaborated with esteemed colleagues, including Donald E Bierer and Jian Luo. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Reimar C Bruening's contributions to the field of pharmaceuticals, particularly in antifungal and hypoglycemic agents, highlight his innovative spirit and dedication to improving health outcomes. His work continues to pave the way for advancements in medical treatments.